Industry News
Immunotherapy breakthrough for advanced bladder cancer
Nov 28, 2014
An antibody drug that stops cancer cells evading the immune system helps achieve a breakthrough in developing a new therapy for advanced bladder cancer. Read More
More public health interventions required to tackle grim reaper of 'lifestyle' diseases
Nov 28, 2014
More public health interventions, along the lines of the smoking ban, are needed to tackle Britain's devastating toll of 'lifestyle' diseases, including heart disease and cancer, according to... Read More
Saatchi Bill threatens to undermine Hippocratic Oath
Nov 28, 2014
The Medical Innovation Bill tabled by Lord Saatchi and currently making its way through the UK's House of Lords "strikes at the heart of evidence-based medicine" and risks "opening the door to the... Read More
Scientists discover way to target rare breast cancer mutation
Nov 28, 2014
UK scientists have identified a drug to target a rare breast cancer mutation that helps drive the disease in around 900 of the 50,000 new cases of breast cancer diagnosed in the UK each year. Read More
Innovative technique for monitoring the physical activity of people with haemophilia
Nov 28, 2014
The research group Intelligent Data Analysis Laboratory from the School of Engineering Universitat de València (UV) and a team of scientists at the Faculty of Physiotherapy led by Professor Felipe... Read More
NICE issues final positive recommendation for national commissioning of Soliris for patients with atypical hemolytic uremic syndrome (aHUS)
Nov 28, 2014
Alexion Pharmaceuticals, Inc. has announced that the National Institute for Health and Care Excellence (NICE) Highly Specialised Technologies Evaluation Committee (EC) has recommended that... Read More
Long-term testosterone therapy does not increase the risk of prostate cancer
Nov 28, 2014
Testosterone (T) therapy is routinely used in men with hypogonadism, a condition in which diminished function of the gonads occurs. Read More
Survival differences seen for advanced-stage laryngeal cancer
Nov 28, 2014
The five-year survival rate for advanced-stage laryngeal cancer was higher than national levels in a small study at a single academic center performing a high rate of surgical therapy, including a... Read More
Gene mutation linked to breast cancer therapy resistance
Nov 28, 2014
A group of Vanderbilt-led investigators has identified a new gene mutation that may explain why some breast cancer patients do not respond to anti-hormone therapy. Read More
AG-120 in IDH1 mutated acute myeloid leukemia shows "dramatic" early phase 1 results
Nov 28, 2014
Results presented by University of Colorado Cancer Center investigator Daniel Pollyea, MD, MS, at the 26th European Organisation for Research and Treatment of Cancer Symposium in Barcelona show... Read More
Previous Page Next Page